Deschatelets Pascal (CIK 0001657720)

Latest company ownership

APLS - Apellis Pharmaceuticals, Inc.
Role: Chief Scientific Officer
Shares held
12,780
Last filed at
May 22, 2025
Confidence Score
50.3
2025Q4
Confidence Score History
2019Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 29, 2025 Jan 30, 2025 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 51.3 -826 -0.07% ✗ $24.4K
Jan 22, 2025 Jan 23, 2025 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 47.5 -3,948 -0.34% ✗ $120.1K
Jan 17, 2025 Jan 21, 2025 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 78.8 +14,295 1.26% ✗ $22.5K
Jan 13, 2025 Jan 14, 2025 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 47.5 -2,288 -0.20% ✗ $65.7K
May 8, 2024 May 9, 2024 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 27.5 -78,907 -6.60% ✓ $3.3M
Apr 8, 2024 Apr 9, 2024 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 27.5 -69,107 -5.83% ✓ $3.7M
Mar 8, 2024 Mar 11, 2024 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 27.5 -69,107 -5.83% ✓ $4.3M
Feb 12, 2024 Feb 13, 2024 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 47.5 -1,148 -0.10% ✗ $77.8K
Jan 29, 2024 Jan 31, 2024 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 47.5 -874 -0.08% ✗ $56.1K
Jan 22, 2024 Jan 23, 2024 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 45.0 -3,913 -0.35% ✗ $254.3K
Jan 16, 2024 Jan 17, 2024 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 65.0 +5,111 0.46% ✗ $109K
Nov 8, 2023 Nov 9, 2023 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 42.5 -12,000 -1.11% ✓ $567.2K
Oct 9, 2023 Oct 10, 2023 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 42.5 -12,000 -1.11% ✓ $484.6K
Sep 8, 2023 Sep 11, 2023 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 42.5 -12,000 -1.12% ✓ $514.4K
Aug 8, 2023 Aug 9, 2023 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 42.5 -12,000 -1.13% ✓ $283.9K
Jul 10, 2023 Jul 11, 2023 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 40.0 -12,000 -1.13% ✓ $1M
Jun 8, 2023 Jun 9, 2023 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 40.0 -12,000 -1.14% ✓ $1.1M
May 8, 2023 May 9, 2023 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 40.0 -12,000 -1.15% ✓ $1.1M
Apr 10, 2023 Apr 11, 2023 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 42.5 -12,000 -1.15% ✓ $938.5K
Mar 8, 2023 Mar 10, 2023 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 42.5 -12,000 -1.16% ✓ $765.5K
Feb 21, 2023 Feb 22, 2023 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 72.5 +8,691 0.86% ✗ $69.9K
Feb 10, 2023 Feb 14, 2023 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 47.5 -1,134 -0.11% ✗ $58.1K
Feb 8, 2023 Feb 10, 2023 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 42.5 -12,000 -1.18% ✓ $653.4K
Jan 27, 2023 Jan 30, 2023 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 51.3 -832 -0.08% ✗ $43.9K
Jan 20, 2023 Jan 24, 2023 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 40.0 -2,326 -0.23% ✗ $121.1K
Jan 9, 2023 Jan 10, 2023 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 42.5 -12,000 -1.21% ✓ $553K
Dec 8, 2022 Dec 12, 2022 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 42.5 -12,000 -1.22% ✓ $570K
Nov 8, 2022 Nov 10, 2022 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 42.5 -12,000 -1.23% ✓ $557.6K
Oct 10, 2022 Oct 11, 2022 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 42.5 -12,000 -1.24% ✓ $690K
Sep 8, 2022 Sep 12, 2022 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 42.5 -12,000 -1.25% ✓ $767.8K
Aug 8, 2022 Aug 9, 2022 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 42.5 -12,000 -1.25% ✓ $750K
Jul 8, 2022 Jul 12, 2022 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 42.5 -12,000 -1.26% ✓ $575.4K
Jun 8, 2022 Jun 9, 2022 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 42.5 -12,000 -1.33% ✓ $529.1K
Apr 21, 2022 May 2, 2022 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 48.8 -5,875 -0.33% ✓ $177.7K
Feb 10, 2022 Feb 14, 2022 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 51.3 -1,057 -0.12% ✗ $49.8K
Jan 28, 2022 Feb 1, 2022 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 51.3 -931 -0.10% ✗ $35.9K
Jun 24, 2021 Jun 25, 2021 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 45.0 -6,250 -0.71% ✓ $410.1K
May 24, 2021 May 25, 2021 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 45.0 -6,250 -0.71% ✓ $296.3K
Apr 23, 2021 Apr 26, 2021 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 45.0 -6,250 -0.72% ✓ $288.3K
Mar 10, 2021 Mar 11, 2021 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 30.0 -6,250 -0.72% ✗ $317.1K
Feb 10, 2021 Feb 11, 2021 Apellis Pharmaceuticals, Inc. Chief Scientific Officer Sell 51.3 -688 -0.08% ✗ $32.8K
Feb 12, 2020 Feb 14, 2020 Apellis Pharmaceuticals, Inc. COO Sell 27.5 -107,473 -5.21% ✓ $4.5M
Sep 25, 2019 Sep 26, 2019 Apellis Pharmaceuticals, Inc. COO Sell 38.8 -21,541 -2.38% ✓ $544.1K
Sep 23, 2019 Sep 25, 2019 Apellis Pharmaceuticals, Inc. COO Sell 32.5 -42,460 -4.49% ✓ $1.1M